Delivery Order SPE2DB22D3016-SPE2DB25FBHB0
- Not listed
- The Defense Logistics Agency awarded a $1,434.04 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml quantities. This firm fixed-price contract, with an ultimate completion date of August 25, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical vendors....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,935.80 firm fixed-price delivery order is for the supply of Olopatadine HCl 0.1% eye drops in 5ml bottles. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $3,580.00 and a period of performance through April 2025. It is a Firm Fixed Price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.20 delivery order is for the supply of Olopatadine HCL 0.1% eye drops in 5ml containers. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $1,297.14 delivery order is a firm-fixed price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML. The firm-fixed-price delivery order, valued at $1,115.33, has a completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,090.15 award is for the provision of 4,564,247,570 units of Olopatadine HCL 0.1% eye drops in 5ml containers. No set-aside designation was used. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml vials, with a total ceiling value of $1,696.92 and a completion date of January 27, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition....
- This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHB0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its comprehensive supply of pharmaceuticals, vaccines, and medical devices to military and veteran healthcare systems. The company's SPE2DX prime vendor contract serves as a global pharmaceutical support vehicle enabling supply to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for olopatadine eye drops continues AmerisourceBergen's role in fulfilling DLA's pharmaceutical distribution requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |